| Dina Esterowitz, MD | |
|
2001 Medical Pkwy, Annapolis, MD 21401-3280 | |
| (443) 481-1366 | |
| Not Available |
| Full Name | Dina Esterowitz |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 2001 Medical Pkwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700990975 | NPI | - | NPPES |
| 60055702 | Other | MD | BLUE SHIELD |
| T2390006 | Other | DC | GHI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | D56809 (Maryland) | Primary |
| Entity Name | Doctors Emergency Service, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528171840 PECOS PAC ID: 4486644598 Enrollment ID: O20040512001075 |
News Archive
One hundred million treatments of Coartem- Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with Plasmodium falciparum malaria, have been delivered by Novartis to 39 malaria-endemic countries, Medicines for Malaria Venture (MMV) announced today.
National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving poster and oral presentations on results from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana.
MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment and advance the traditional medication formulary program upstream in the value chain to the point of care.
Springer is launching the AJCC e-Staging Tool, a web-based application which will improve the way cancer is staged. Designed to meet the needs of the entire multidisciplinary team in any facility that deals with cancer, the AJCC e-Staging Tool makes the process quicker, more efficient and more accurate. The content draws from the highly successful AJCC Cancer Staging Manual, 7th edition, published by Springer in 2010.
› Verified 6 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
One hundred million treatments of Coartem- Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with Plasmodium falciparum malaria, have been delivered by Novartis to 39 malaria-endemic countries, Medicines for Malaria Venture (MMV) announced today.
National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving poster and oral presentations on results from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana.
MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment and advance the traditional medication formulary program upstream in the value chain to the point of care.
Springer is launching the AJCC e-Staging Tool, a web-based application which will improve the way cancer is staged. Designed to meet the needs of the entire multidisciplinary team in any facility that deals with cancer, the AJCC e-Staging Tool makes the process quicker, more efficient and more accurate. The content draws from the highly successful AJCC Cancer Staging Manual, 7th edition, published by Springer in 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dina Esterowitz, MD 2001 Medical Pkwy, Annapolis, MD 21401-3280 Ph: (443) 481-1366 | Dina Esterowitz, MD 2001 Medical Pkwy, Annapolis, MD 21401-3280 Ph: (443) 481-1366 |
News Archive
One hundred million treatments of Coartem- Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with Plasmodium falciparum malaria, have been delivered by Novartis to 39 malaria-endemic countries, Medicines for Malaria Venture (MMV) announced today.
National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving poster and oral presentations on results from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) at Digestive Disease Week (DDW) 2010 in New Orleans, Louisiana.
MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment and advance the traditional medication formulary program upstream in the value chain to the point of care.
Springer is launching the AJCC e-Staging Tool, a web-based application which will improve the way cancer is staged. Designed to meet the needs of the entire multidisciplinary team in any facility that deals with cancer, the AJCC e-Staging Tool makes the process quicker, more efficient and more accurate. The content draws from the highly successful AJCC Cancer Staging Manual, 7th edition, published by Springer in 2010.
› Verified 6 days ago
Dr. Cornelius Van Der Meer Stamp, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 821 Bay Ridge Ave, Apt A, Annapolis, MD 21403 Phone: 410-268-9590 | |
Bailey E Lewis, ATC Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 566 Brownson Rd, Annapolis, MD 21402 Phone: 269-319-9216 | |
Lee A. Goodman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 79 West St, Annapolis, MD 21401 Phone: 410-268-3627 Fax: 410-267-6372 | |
Jared Kartchner Heal, DO, UMO/DMO USN Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 Blake Rd, Annapolis, MD 21402 Phone: 710-293-1706 | |
Caitlin Mase, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1366 | |
Frederick K Goodwin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1366 | |
Joseph A Halpern, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1366 |